1800-272-662
Shopping Cart 0
countryflagAU
Login

Goodrx Holdings Inc

Healthcare US GDRX

2.4USD
0.05(2.13%)

Last update at 2026-03-10T20:11:00Z

Day Range

2.342.46
LowHigh

52 Week Range

4.139.37
LowHigh

Fundamentals

  • Previous Close 2.35
  • Market Cap2727.74M
  • Volume3501651
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA77.07M
  • Revenue TTM764.16M
  • Revenue Per Share TTM1.89
  • Gross Profit TTM 701.48M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -23.23100M -10.17700M -303.45000M 82.98M 52.35M
Minority interest - - - - -
Net income -32.82800M -25.25400M -293.62300M 66.05M 43.79M
Selling general administrative 144.79M 154.69M 461.45M 14.69M 8.36M
Selling and marketing expenses 357.63M 370.22M 255.13M 176.97M 104.18M
Gross profit 701.48M 698.71M 521.11M 374.21M 243.49M
Reconciled depreciation 54.18M 34.54M 18.43M 13.57M 9.81M
Ebit 11.01M 13.41M -275.71900M 139.68M 77.40M
Ebitda 65.19M 48.00M -257.10700M 151.00M 87.20M
Depreciation and amortization 54.18M 34.60M 18.61M 11.32M 9.81M
Non operating income net other 9.27M 0.06M 0.18M - -
Operating income 11.01M 13.41M -275.71900M 139.68M 77.25M
Other operating expenses 764.82M 732.02M 826.42M 248.55M 172.27M
Interest expense 34.24M 23.64M 27.91M 49.57M 22.19M
Tax provision 9.60M 15.08M -9.82700M 16.93M 8.55M
Interest income 9.27M 0.06M 0.16M 0.71M 0.15M
Net interest income -24.96900M -23.58300M -27.75300M -48.85400M -22.03900M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 9.60M 15.08M -9.82700M 16.93M 8.55M
Total revenue 766.55M 745.42M 550.70M 388.22M 249.52M
Total operating expenses 699.74M 685.30M 796.83M 234.53M 166.24M
Cost of revenue 65.08M 46.72M 29.59M 14.02M 6.04M
Total other income expense net -34.24300M -23.58300M -27.73100M -56.69800M -2.86400M
Discontinued operations - - - - -
Net income from continuing ops -32.82800M -25.25400M -293.62300M 66.05M 43.79M
Net income applicable to common shares -32.82800M -25.25400M -293.62300M 42.44M 13.79M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 1588.80M 1604.63M 1607.62M 1470.11M 386.80M
Intangible assets 156.34M 189.94M 133.78M 56.72M 26.45M
Earning assets - - - - -
Other current assets 40.45M 45.38M 29.64M 46.05M 5.01M
Total liab 826.84M 789.80M 775.95M 758.75M 1474.38M
Total stockholder equity 761.96M 814.83M 831.68M 711.36M -1087.58200M
Deferred long term liab - - - - -
Other current liab 64.22M 39.64M 43.86M 30.84M 12.10M
Common stock 0.04M 0.04M 0.04M 0.04M 0.46M
Capital stock 0.04M 0.04M 0.04M 0.04M 0.46M
Retained earnings -1457.40300M -1448.53500M -1415.70700M -1390.45300M -1096.83000M
Other liab - 7.56M 5.38M 5.85M 2.97M
Good will 410.77M 412.12M 329.70M 261.12M 236.22M
Other assets - 8.16M 6.01M 15.14M 3.37M
Cash 672.30M 757.16M 941.11M 968.69M 26.05M
Cash and equivalents - - - - -
Total current liabilities 122.56M 76.32M 81.11M 59.55M 33.37M
Current deferred revenue 7.11M 7.88M 6.87M 6.85M 3.45M
Net debt 38.77M -40.14100M -238.77900M -263.76800M 684.94M
Short term debt 14.96M 11.10M 12.88M 11.57M 9.97M
Short long term debt 8.79M 7.03M 7.03M 7.03M 7.03M
Short long term debt total 711.07M 717.02M 702.33M 704.92M 710.99M
Other stockholder equity 2219.32M 2263.32M 2247.35M 2101.77M 8.79M
Property plant equipment - 19.82M 21.61M 50.77M 34.17M
Total current assets 872.79M 919.69M 1088.83M 1086.37M 86.58M
Long term investments - - - - -
Net tangible assets - 814.83M 831.68M 393.52M -1350.25200M
Short term investments - - - - -
Net receivables 160.04M 117.14M 126.41M 68.73M 55.52M
Long term debt 647.70M 651.80M 655.86M 659.89M 663.89M
Inventory 0.00000M - -8.33100M 2.90M -
Accounts payable 36.27M 17.70M 17.50M 10.29M 7.85M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.00000M - - -1470.11400M -1.26700M
Additional paid in capital - - - - -
Common stock total equity - 0.04M 0.04M 0.04M 0.46M
Preferred stock total equity - - - - -
Retained earnings total equity - -1448.53500M -1415.70700M -1390.45300M -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 22.77M 27.16M 6.01M 2.02M 1.16M
Deferred long term asset charges - - - - -
Non current assets total 716.01M 684.95M 518.80M 383.75M 300.21M
Capital lease obligations 54.58M 58.20M 39.44M 38.01M 40.07M
Long term debt total - - - 659.89M -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -210.49800M -178.73300M -91.61700M -37.05500M -3.45800M
Change to liabilities -4.01700M 17.50M 2.15M 0.52M 0.67M
Total cashflows from investing activities -210.49800M -178.73300M -91.61700M -37.05500M -3.45800M
Net borrowings -7.02900M -7.02900M -7.02900M -57.23200M 606.88M
Total cash from financing activities -120.22600M -30.52800M 905.82M -54.78100M -24.73400M
Change to operating activities -20.79100M 27.95M -18.47400M 9.19M 0.41M
Net income -32.82800M -25.25400M -293.62300M 66.05M 43.79M
Change in cash -183.94400M -30.48200M 945.54M -8.55000M 17.06M
Begin period cash flow 941.11M 971.59M 26.05M 34.60M 17.54M
End period cash flow 757.16M 941.11M 971.59M 26.05M 34.60M
Total cash from operating activities 146.78M 178.78M 131.34M 83.29M 45.25M
Issuance of capital stock 0.00000M 0.00000M 991.79M 1.62M 737.01M
Depreciation 54.18M 34.54M 18.43M 13.57M 9.81M
Other cashflows from investing activities -206.53100M -174.16200M -71.06400M - -
Dividends paid - - 0.00000M 0.00000M 1346.36M
Change to inventory - - -21.34900M 9.02M -2.55000M
Change to account receivables 1.38M -43.94900M -16.13900M -14.51700M -12.84300M
Sale purchase of stock -101.72100M 35.02M 992.20M - -
Other cashflows from financing activities -20.63500M -23.49900M -50.94700M 155.44M 1616.56M
Change to netincome 126.39M 173.31M 435.60M 5.10M 2.19M
Capital expenditures 55.21M 34.46M 35.82M 5.75M 3.46M
Change receivables 1.38M -43.94900M -16.13900M - -
Cash flows other operating -1.73000M -14.93200M 10.80M - -
Exchange rate changes - - - - -
Cash and cash equivalents changes -183.94400M -30.48200M 945.54M - -
Change in working capital -20.29000M -11.79600M -32.45900M -4.81600M -11.77100M
Stock based compensation 120.23M 160.46M 397.29M 3.75M 1.76M
Other non cash items 25.98M 7.98M 52.62M 10.41M 4.10M
Free cash flow 91.57M 144.32M 95.52M 77.54M 41.80M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
GDRX
Goodrx Holdings Inc		 0.05 2.13% 2.40 - 20.49 3.60 3.54 3.65 25.15
GEHC
GE HealthCare Technologies Inc.		 -2.9 3.83% 72.73 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A		 -5.88 3.01% 189.69 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 11.42 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 -0.07 1.34% 5.17 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

View All

Profile

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Goodrx Holdings Inc

2701 Olympic Boulevard, Santa Monica, CA, United States, 90404

Key Executives

Name Title Year Born
Mr. Douglas Joseph Hirsch Co-founder, Co-CEO & Director 1971
Mr. Trevor Bezdek Co-founder, Co-CEO, Sec. & Director 1978
Mr. Karsten Ian Voermann CFO & Principal Financial Officer 1970
Mr. Babak Azad Chief Marketing Officer and SVP of Marketing & Communications 1973
Mr. Bansi Nagji Pres of Healthcare 1965
Mr. Raj Beri Chief Operating Officer NA
Mr. Romin Nabiey Chief Accounting Officer & Principal Accounting Officer 1987
Ms. Whitney Notaro VP of Investor Relations NA
Ms. Vina M. Leite Chief People Officer 1969
Mr. Justin Fengler Sr. VP of Corp. Strategy & Bus. Operations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.